This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1976-1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wuppertal, DE (1976)
- Wuppertal-Elberfeld, DE (1977)
Company Filing History:
Years Active: 1976-1977
Title: Hinrich Otten: Innovator in Antibacterial Agents
Introduction
Hinrich Otten is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of antibacterial agents, particularly in the fight against mycobacterial infections. With a total of 2 patents, Otten's work is recognized for its innovative approach to developing effective treatments.
Latest Patents
Otten's latest patents include groundbreaking compounds that target mycobacterium infections. The first patent focuses on benzoic acid amides characterized by the presence of a hydroxy or amino substituent in the phenyl ring. These compounds, such as N-[pyridyl-(2)-methyl]-2-hydroxybenzoic acid amide, are designed as antibacterial agents, specifically targeting tuberculosis. The preparation involves the reaction of an appropriately substituted benzoic acid with an appropriate amine.
The second patent involves pyridine carboxylic acid amides, which also serve as antibacterial agents. These compounds are characterized by various substituents in the phenyl ring and include N-(pyrid-2-yl-methyl)3,5-dinitrobenzoic acid amide as a typical embodiment. Similar to the first patent, these compounds are prepared through a reaction of substituted benzoic acids with appropriate amines.
Career Highlights
Hinrich Otten is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on innovative solutions for combating bacterial infections, contributing to the advancement of medical science.
Collaborations
Otten has collaborated with esteemed colleagues such as Hans-Joachim Kabbe and Karl Heinrich Mayer. These collaborations have fostered a productive environment for research and development in the field of antibacterial agents.
Conclusion
Hinrich Otten's contributions to the development of antibacterial agents highlight his innovative spirit and dedication to improving healthcare. His patents represent significant advancements in the treatment of mycobacterial infections, showcasing the importance of research and collaboration in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile